Targeting the Immune Niche within the Bone Marrow Microenvironment: The Rise of Immunotherapy in Multiple Myeloma

PD-1 blockade enhances the vaccination-induced immune response in glioma

Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors

Emerging immunotherapies for glioblastoma

Overcoming Barriers in Oncolytic Virotherapy with HDAC Inhibitors and Immune Checkpoint Blockade

Fueling the engine and releasing the break: combinational therapy of cancer vaccines and immune checkpoint inhibitors

Rationale for a Multimodality Strategy to Enhance the Efficacy of Dendritic Cell-Based Cancer Immunotherapy

Classifying Cancers Based on T-cell Infiltration and PD-L1

Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential

Potentiation of immune checkpoint blockade cancer immunotherapy with oncolytic virus.